Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment

Glecaprevir/pibrentasvir in combination with sofosbuvir may serve as a safe and effective option for treatment of recurrent hepatitis C virus post-liver transplant in patients who previously failed direct-acting antivirals.

Detalles Bibliográficos
Autores principales: Arora, Rishi, Martin, Michelle T, Boike, Justin, Patel, Sonalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011907/
https://www.ncbi.nlm.nih.gov/pubmed/36926235
http://dx.doi.org/10.4254/wjh.v15.i2.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011907/
https://www.ncbi.nlm.nih.gov/pubmed/36926235
http://dx.doi.org/10.4254/wjh.v15.i2.318

Ejemplares similares